Page 462 - IJB-10-6

International Journal of Bioprinting 3D-printed scaffold for biomolecule delivery

Conflict of interest adhesion mechanism. Eur Cell Mater. 2014;28:387-403.
doi: 10.22203/ecm.v028a27
The authors have no competing interests to declare.
7. Shah NJ, Hyder MN, Quadir MA, et al. Adaptive growth
Author contributions factor delivery from a polyelectrolyte coating promotes
synergistic bone tissue repair and reconstruction. Proc Natl
Conceptualization: Jong-Eun Won, Hae-Won Kim Acad Sci USA. 2014;111(35):12847-12852.
Formal analysis: Jong-Eun Won, Hyun Kyung Moon doi: 10.1073/pnas.1408035111
Investigation: Jong-Eun Won 8. Kuttappan S, Mathew D, Jo JI, et al. Dual release of growth
Methodology: Jong-Eun Won factor from nanocomposite fibrous scaffold promotes
Writing – original draft: Jong-Eun Won, Ji Suk Shim vascularisation and bone regeneration in rat critical sized
Writing – review & editing: Jong-Eun Won, Hae-Won Kim, calvarial defect. Acta Biomater. 2018;78:36-47.
Ji Suk Shim doi: 10.1016/j.actbio.2018.07.050
9. Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA.
Ethics approval and consent to participate Growth factor regulation of fracture repair. J Bone Miner
This work was approved by Animal Care and Use Res. 1999;14(11):1805-1815.
Committee of the Korea University (KOREA-2021-0004). doi: 10.1359/jbmr.1999.14.11.1805
All necessary ethical guidelines have been followed, and 10. Termaat MF, Den Boer FC, Bakker FC, Patka P, Haarman
relevant documentation is available upon request. HJ. Bone morphogenetic proteins. Development and clinical
efficacy in the treatment of fractures and bone defects.
Consent for publication J Bone Joint Surg Am. 2005;87(6):1367-1378.
doi: 10.2106/JBJS.D.02585
Not applicable.
11. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H.
Availability of data Evaluation of recombinant human bone morphogenetic
protein-2 in oral applications including the use of
Data is available from the corresponding author upon endosseous implants: 3-year results of a pilot study in
reasonable request. humans. J Periodontol. 2000;71(8):1241-1257.
doi: 10.1902/jop.2000.71.8.1241
References 12. Epstein SE, Fuchs S, Zhou YF, Baffour R, Kornowski
R. Therapeutic interventions for enhancing collateral
1. Hussey GS, Dziki JL, Badylak SF. Extracellular matrix- development by administration of growth factors: basic
based materials for regenerative medicine. Nat Rev Mater. principles, early results and potential hazards. Cardiovasc
2018;3(7):159-173. Res. 2001;49(3):532-542.
doi: 10.1038/s41578-018-0023-x doi: 10.1016/s0008-6363(00)00217-0
2. Won JE, Lee YS, Park JH, et al. Hierarchical microchanneled 13. Freeman FE, Pitacco P, van Dommelen LHA, et al. 3D
scaffolds modulate multiple tissue-regenerative processes bioprinting spatiotemporally defined patterns of growth
of immune-responses, angiogenesis, and stem cell homing. factors to tightly control tissue regeneration. Sci Adv.
Biomaterials. 2020;227:119548. 2020;6(33):eabb5093.
doi: 10.1016/j.biomaterials.2019.119548 doi: 10.1126/sciadv.abb5093
3. Babensee JE, McIntire LV, Mikos AG. Growth factor delivery 14. Oliveira ER, Nie L, Podstawczyk D, et al. Advances in
for tissue engineering. Pharm Res. 2000;17(5):497-504. growth factor delivery for bone tissue engineering. Int J
doi: 10.1023/a:1007502828372 Mol Sci. 2021;22(2):903-935.
4. Wang ZM, Wang ZF, Lu WW, Zhen WX, Yang DZ, Peng SL. doi: 10.3390/ijms22020903
Novel biomaterial strategies for controlled growth factor 15. Nyberg E, Holmes C, Witham T, Grayson WL. Growth
delivery for biomedical applications. NPG Asia Mater. factor-eluting technologies for bone tissue engineering.
2017;9:e435-451. Drug Deliv Transl Res. 2016;6(2):184-194.
doi: 10.1038/am.2017.171 doi: 10.1007/s13346-015-0233-3
5. Yun YR, Jang JH, Jeon E, et al. Administration of growth 16. Keceli HG, Bayram C, Celik E, Ercan N, Demirbilek M,
factors for bone regeneration. Regen Med. 2012;7(3): Nohutcu RM. Dual delivery of platelet-derived growth
369-385. factor and bone morphogenetic factor-6 on titanium surface
doi: 10.2217/rme.12.1 to enhance the early period of implant osseointegration.
6. Kang J, Park HM, Kim YW, et al. Control of mesenchymal J Periodontal Res. 2020;55(5):694-704.
stem cell phenotype and differentiation depending on cell doi: 10.1111/jre.12756

Volume 10 Issue 6 (2024) 454 doi: 10.36922/ijb.4638